DGAP-News: Vivoryon Therapeutics AG
/ Key word(s): Miscellaneous
19.11.2020 / 07:00
The issuer is solely responsible for the content of this announcement.
Vivoryon Therapeutics AG to Publish its Third Quarter 2020 Business Update on November 26, 2020
HALLE (SAALE) / Munich, Germany, 19 November 2020 – Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), a biotechnology company focused on developing first-in-class therapeutics targeting post-translational modifying enzymes, announced today that it will publish its third quarter business update for the period ended September 30, 2020 on Thursday, November 26, 2020, in the form of an interim management report.
For more information, please contact:
About Vivoryon Therapeutics AG
Forward Looking Statements
19.11.2020 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||Vivoryon Therapeutics AG|
|Phone:||+49 (0)345 555 9900|
|Fax:||+49 (0)345 555 9901|
|Listed:||Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart; Amsterdam|
|EQS News ID:||1149141|
|End of News||DGAP News Service|